SCHEMBL13311712

SCHEMBL13311712

CSC1CC(=O)N(CCC(=O)NCCNC(=O)CC(CC(=O)NCCNC(=O)CCN2C(=O)CC(SF)C2=O)C(C)=O)C1=O

nearest known ligand 0.32

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.32
▸ FOLH1 Q04609 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ HDAC3 O15379 1/20 0.31
▸ HDAC4 P56524 1/20 0.31
▸ HDAC1 Q13547 1/20 0.31
▸ HDAC7 Q8WUI4 1/20 0.31
▸ HDAC2 Q92769 1/20 0.31
▸ HDAC10 Q969S8 1/20 0.31
▸ HDAC11 Q96DB2 1/20 0.31
▸ HDAC8 Q9BY41 1/20 0.31
▸ HDAC6 Q9UBN7 1/20 0.31
▸ HDAC9 Q9UKV0 1/20 0.31
▸ HDAC5 Q9UQL6 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2607947 0.95 FOLH1 (0.33) ALDH1A1FOLH1POLBHSD17B10HDAC3
SCHEMBL12107731 0.84 HDAC3 (0.36) ALDH1A1FOLH1POLBHSD17B10HDAC3
SCHEMBL18081560 0.83 ALDH1A1 (0.37) ALDH1A1FOLH1POLBHSD17B10HDAC3
SCHEMBL15725708 0.83 FOLH1 (0.34) ALDH1A1FOLH1POLBHSD17B10HDAC3
SCHEMBL14755921 0.82 ALDH1A1 (0.35) ALDH1A1FOLH1POLBHSD17B10HDAC3
SCHEMBL15144373 0.82 FOLH1 (0.34) ALDH1A1FOLH1POLBHSD17B10HDAC3
SCHEMBL12382220 0.82 FOLH1 (0.35) ALDH1A1FOLH1POLBHSD17B10HDAC3
SCHEMBL12973764 0.81 POLB (0.31) POLBHSD17B10
SCHEMBL13225546 0.80 HDAC3 (0.35) ALDH1A1POLBHSD17B10HDAC3HDAC4
SCHEMBL16328730 0.80 ALDH1A1 (0.39) ALDH1A1FOLH1POLBHSD17B10HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100137511-A1 POLYMER FACTOR IX MOIETY CONJUGATES NEKTAR THERAPEUTICS (US) 2010-06-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137511-A1 POLYMER FACTOR IX MOIETY CONJUGATES F9, F13A1, F8 ALDH1A1 3118/4885FOLH1 131/4885POLB 1490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback